Cell Impact delivers flow plates and test tools to a major player in Asia

19.05.25 11:20 Uhr

Werte in diesem Artikel

KARLSKOGA, Sweden, May 19, 2025 /PRNewswire/ -- Cell Impact AB (publ) has signed an agreement to deliver test tools to a leading industrial player in Asia. The deal confirms Cell Impact's attractive offering and its unique forming technology.

The agreement is a follow-up order from a customer with whom Cell Impact has previously conducted development projects.

 

Cell Impact AB (publ) has signed an agreement to deliver test tools to a leading industrial player in Asia. The deal confirms Cell Impact's attractive offering and Cell Impact Forming™, its unique forming technology that is significantly more scalable and cost-efficient compared to conventional forming methods.

 

"The tests of our forming technology conducted by this customer have been successful, which has laid the foundation for today's agreement. This is a process we have seen before. Successful tests of Cell Impact Forming™ lead to new business, which in turn is a prerequisite for future volume production," says Mr. Daniel Vallin, CEO of Cell Impact.

The order includes both flow plates and a test tool that will be used to manufacture customized flow plates. Delivery will take place during the second quarter, and the order value amounts to MSEK 0.6.

Photo: https://mma.prnewswire.com/media/2690599/Cell_Impact.jpg

For more information, please contact:
Daniel Vallin
CEO and IR contact, Cell Impact AB (publ)
+46730686620 or daniel.vallin@cellimpact.com 

About Cell Impact

Cell Impact AB (publ) is a global supplier of advanced flow plates to fuel cell and electrolyzer manufacturers. The company has developed and patented a unique method for high velocity forming, Cell Impact Forming™ which is significantly more scalable and cost-efficient compared to conventional forming methods. Cell Impact Forming is an environmentally friendly forming technology that consumes no water and very little electrical power.

The Cell Impact share is listed on Nasdaq First North Growth Market and FNCA Sweden AB is the company's Certified Advisor (CA).

SOURCE Cell Impact

In eigener Sache

Übrigens: The Cigna Group Registered und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf The Cigna Group Registered

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf The Cigna Group Registered

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu The Cigna Group Registered Shs

Wer­bung

Analysen zu The Cigna Group Registered Shs

DatumRatingAnalyst
20.07.2018Express Scripts NeutralRobert W. Baird & Co. Incorporated
08.03.2018Express Scripts Equal WeightBarclays Capital
08.03.2018Cigna OverweightBarclays Capital
31.01.2018Express Scripts OutperformRBC Capital Markets
15.12.2017Express Scripts OutperformRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
08.03.2018Cigna OverweightBarclays Capital
31.01.2018Express Scripts OutperformRBC Capital Markets
15.12.2017Express Scripts OutperformRobert W. Baird & Co. Incorporated
14.12.2017Express Scripts BuyMaxim Group
04.12.2017Express Scripts BuyDeutsche Bank AG
DatumRatingAnalyst
20.07.2018Express Scripts NeutralRobert W. Baird & Co. Incorporated
08.03.2018Express Scripts Equal WeightBarclays Capital
19.09.2017Express Scripts Sector PerformRBC Capital Markets
21.07.2017Express Scripts HoldNeedham & Company, LLC
26.04.2017Express Scripts HoldEdward Jones
DatumRatingAnalyst
22.02.2016Express Scripts SellDeutsche Bank AG
13.01.2009CIGNA sellCitigroup Corp.
07.11.2007CIGNA underweightLehman Brothers Inc.
02.11.2006Update CIGNA Corp.: UnderweightLehman Brothers

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für The Cigna Group Registered Shs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen